Physician profile
Claudia Nadine Ye
NPI 1801962535
$585.35
in general payments reported to CMS, 2019-2025
11 companies · $266 in 2025
The $266 reported for 2025 was more than what 79% of Women'S Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $158 · 2022: $24.20 · 2023: $58.01 · 2024: $78.31 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $309 · Education: $93.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $308.82 |
| Education | $93.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $181.73 | 2023-2025 | Annovera |
| Astellas Pharma US INC | $93.95 | 2025 | |
| Hologic Sales and Service, LLC | $64.17 | 2024-2025 | Aptima |
| Abbvie INC. | $57.89 | 2021 | |
| Roche Diagnostics Corporation | $56.96 | 2021 | |
| Coopersurgical, INC. | $29.25 | 2024 | Paragard T 380a |
| Merck Sharp & Dohme LLC | $24.28 | 2021 | |
| Organon LLC | $24.20 | 2022 | |
| Aspira Women'S Health INC | $20.42 | 2023 | Ova1 |
| Therapeuticsmd, INC. | $19.25 | 2021 | |
| Daiichi Sankyo INC. | $13.25 | 2024 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claudia Ye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.